Pharvaris N.V. PHVS
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.36M | 15.67M | 11.52M | 11.52M | 12.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.07M | 55.41M | 46.37M | 46.37M | 45.82M |
| Operating Income | -59.07M | -55.41M | -46.37M | -46.37M | -45.82M |
| Income Before Tax | -54.94M | -52.47M | -43.63M | -43.63M | -51.39M |
| Income Tax Expenses | 700.40K | 1.94M | -212.20K | -212.20K | 230.10K |
| Earnings from Continuing Operations | -55.64M | -54.41M | -43.42M | -43.42M | -51.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.64M | -54.41M | -43.42M | -43.42M | -51.62M |
| EBIT | -59.07M | -55.41M | -46.37M | -46.37M | -45.82M |
| EBITDA | -58.92M | -55.35M | -46.32M | -46.32M | -45.63M |
| EPS Basic | -0.82 | -0.84 | -0.70 | -0.70 | -0.94 |
| Normalized Basic EPS | -0.50 | -0.50 | -0.44 | -0.44 | -0.59 |
| EPS Diluted | -0.82 | -0.84 | -0.70 | -0.70 | -0.94 |
| Normalized Diluted EPS | -0.50 | -0.50 | -0.44 | -0.44 | -0.59 |
| Average Basic Shares Outstanding | 68.07M | 65.12M | 62.26M | 62.26M | 54.69M |
| Average Diluted Shares Outstanding | 68.07M | 65.12M | 62.26M | 62.26M | 54.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |